282 | DURABLE EFFICACY WITH FIXED‐DURATION EPCORITAMAB + POLATUZUMAB, VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA‐R‐CHP) FOR 1L DLBCL (EPCORE NHL‐5).
Saved in:
| Title: | 282 | DURABLE EFFICACY WITH FIXED‐DURATION EPCORITAMAB + POLATUZUMAB, VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA‐R‐CHP) FOR 1L DLBCL (EPCORE NHL‐5). |
|---|---|
| Authors: | Lavie, D., Kerr, D. A., Avigdor, A., Avivi, I., Belada, D., Abrisqueta, P., Izutsu, K., Grande‐Garcia, C., Yeh, S., Goto, H., Seliem, M., Siddani, S. R., Joshi, N., Noorani, B., Dixit, N., Diness Vindelov, S., Jafarinasabian, P., Thieblemont, C. |
| Source: | Hematological oncology 2025 Supplement; Vol. 43. |
| Journal Info: | Publisher: Wiley-Blackwell ISSN: 0278-0232 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1099-1069 |
|---|---|
| DOI: | 10.1002/hon.70094_282 |
